Published in Clin Biochem Rev on February 01, 2017
Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 33.61
Mass spectrometry-based proteomics. Nature (2003) 28.94
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06
The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics (2002) 16.08
Five years of GWAS discovery. Am J Hum Genet (2012) 12.97
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica (1999) 9.04
Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med (2005) 8.01
Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen (2009) 7.29
Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics (2012) 5.95
Proinflammatory cytokines. Chest (2000) 5.89
Wound healing and its impairment in the diabetic foot. Lancet (2005) 5.63
Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci (2004) 5.59
HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med (2002) 4.13
Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol (2008) 4.05
The cause of venous ulceration. Lancet (1982) 3.76
Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet (2001) 3.70
The model organism as a system: integrating 'omics' data sets. Nat Rev Mol Cell Biol (2006) 3.69
The "trap" hypothesis of venous ulceration. Lancet (1993) 3.67
Localization of the Huntington's disease gene to a small segment of chromosome 4 flanked by D4S10 and the telomere. Cell (1987) 3.11
Pathophysiology of acute wound healing. Clin Dermatol (2007) 2.99
Epidermal stem cells arise from the hair follicle after wounding. FASEB J (2007) 2.81
Leg ulcers. J Am Acad Dermatol (1991) 2.74
Mass spectrometry-based proteomics in cell biology. J Cell Biol (2010) 2.66
Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen (2008) 2.58
The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun (2002) 2.51
The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol (1993) 2.40
Chronic venous disease. N Engl J Med (2006) 2.35
Mass spectrometry for proteomics. Curr Opin Chem Biol (2008) 2.31
Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol (1993) 2.23
Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen (2000) 2.15
Wound repair in the context of extracellular matrix. Curr Opin Cell Biol (1994) 2.14
Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol (1968) 2.11
General principles of wound healing. Surg Clin North Am (1997) 2.04
Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg (1993) 2.00
Dermal pericapillary fibrin in venous disease and venous ulceration. Arch Dermatol (1987) 1.99
Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem (2007) 1.99
Population aging: a comparison among industrialized countries. Health Aff (Millwood) (2000) 1.99
Changes in the aetiological spectrum of leg ulcers after a broad-scale intervention in a defined geographical population in Sweden. Eur J Vasc Endovasc Surg (2012) 1.92
Gene expression profiling of cutaneous wound healing. J Transl Med (2007) 1.91
Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front Biosci (2007) 1.91
Oxidative stress in normal and impaired wound repair. Pharmacol Res (2008) 1.80
Novel insights into wound healing sequence of events. Toxicol Pathol (2007) 1.66
Fate of human keratinocytes during reepithelialization in an organotypic culture model. Lab Invest (1994) 1.61
Oxygen in acute and chronic wound healing. Br J Dermatol (2010) 1.56
Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system. Nat Methods (2013) 1.56
A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol (1994) 1.53
Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen (2000) 1.48
Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil (2005) 1.47
SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occurring before age 40. Thromb Haemost (2006) 1.39
Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology (1997) 1.39
Leg ulcers: a review of their impact on daily life. J Clin Nurs (2004) 1.38
Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen (1996) 1.37
Arterial disease in chronic leg ulceration: an underestimated hazard? Lothian and Forth Valley leg ulcer study. Br Med J (Clin Res Ed) (1987) 1.36
LC-MS-based metabolomics. Mol Biosyst (2011) 1.36
The burden of chronic wounds in the UK. Nurs Times (2008) 1.34
Skin wound healing modulation by macrophages. Int J Clin Exp Pathol (2010) 1.34
Psychological stress and wound healing in humans: a systematic review and meta-analysis. J Psychosom Res (2009) 1.33
Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol Cell Proteomics (2014) 1.33
Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease. Cell (2015) 1.33
Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des (2001) 1.32
Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol (1996) 1.31
Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg (1993) 1.29
Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS. Proteomics (2013) 1.29
The proteolytic environment of chronic wounds. Wound Repair Regen (2000) 1.29
Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen (1994) 1.28
Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol (1995) 1.27
Pathogenesis of primary varicose veins. Br J Surg (2009) 1.27
Positron emission tomography in venous ulceration and liposclerosis: study of regional tissue function. Br Med J (Clin Res Ed) (1983) 1.25
Impediments to wound healing. Am J Surg (1998) 1.23
Epidemiology of chronic venous disease. Phlebology (2008) 1.23
Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res (1998) 1.21
Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg (1993) 1.19
The impact of psychological stress on wound healing: methods and mechanisms. Immunol Allergy Clin North Am (2011) 1.18
Varicose veins and their management. BMJ (2006) 1.18
Elderly persons' experiences of living with venous leg ulcer: living in a dialectal relationship between freedom and imprisonment. Scand J Caring Sci (2001) 1.14
A gene signature of nonhealing venous ulcers: potential diagnostic markers. J Am Acad Dermatol (2008) 1.13
Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen (2006) 1.11
Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J Proteome Res (2010) 1.10
Clinical parameters and transcutaneous oxygen measurements for the prognosis of venous ulcers. J Am Acad Dermatol (1989) 1.10
Psychological factors and delayed healing in chronic wounds. Psychosom Med (2001) 1.10
Physiology of wound healing. Adv Skin Wound Care (2000) 1.10
Cell signalling: growth factors and tyrosine kinase receptors. Clin Transl Oncol (2006) 1.09
Metabolomics. Cell Metab (2007) 1.09
US skin disease assessment: ulcer and wound care. Dermatol Clin (2012) 1.09
Evaluation of diabetic foot ulcer healing with hyperspectral imaging of oxyhemoglobin and deoxyhemoglobin. Diabetes Care (2009) 1.08
Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen (2000) 1.06
Transcutaneous measurements of oxygen tension at edges of leg ulcers: preliminary communication. J R Soc Med (1986) 1.05
Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing. Wound Repair Regen (2011) 1.05
Chemotaxis for human monocytes by fibrinogen-derived peptides. Br J Haematol (1976) 1.04
Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol (1996) 1.04
Marker metabolites can be therapeutic targets as well. Nature (2008) 1.04
Causes, investigation and treatment of leg ulceration. Br J Dermatol (2003) 1.03
Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol (2000) 1.03
Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins. J Vasc Res (2001) 1.03
Measuring the impact of venous leg ulcers on quality of life. J Wound Care (2005) 1.03
Urine metabolomics. Clin Chim Acta (2012) 1.02
Leg ulcer etiology--a cross sectional population study. J Vasc Surg (1991) 1.02